December 26, 2018 - Page 3 of 4

NASDAQ Companies - December 26, 2018

Acer Therapeutics Announces FDA Acceptance of NDA and Priority Review for EDSIVO™ for the Treatment of vEDS

Acer continues progress toward goal of commercializing EDSIVO™ NEWTON, Mass., Dec. 26, 2018 (GLOBE NEWSWIRE) — Acer Therapeutics Inc. (Nasdaq: […]

NASDAQ Companies - December 26, 2018

Sky Solar Holdings, Ltd. Announces TK Interest Purchase and Sale Agreement and Withdrawal of Litigation by Solar Partnership Capital Ltd.

HONG KONG, Dec. 26, 2018 (GLOBE NEWSWIRE) — Sky Solar Holdings, Ltd. (NASDAQ: SKYS) (“Sky Solar” or the “Company”), a […]

NASDAQ Companies - December 26, 2018

Aemetis Closes Non-dilutive $30 Million Equity Investment to Build Biomethane Pipelines and Dairy Digesters to Produce Below Zero Carbon Renewable Natural Gas (RNG)

Investor conference call to be held on January 10, 2018 CUPERTINO, CA, Dec. 26, 2018 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE […]

NASDAQ Companies - December 26, 2018

Opiant Pharmaceuticals Licenses Novel CB-1 Receptor Antagonist for Treatment of Acute Cannabinoid Overdose from Sanofi

Opiant Intends to Initiate Development Efforts in 2019 SANTA MONICA, Calif., Dec. 26, 2018 (GLOBE NEWSWIRE) — Opiant Pharmaceuticals, Inc. […]

NASDAQ Companies - December 26, 2018

GenMark Diagnostics Receives FDA 510(k) Market Clearance for its ePlex Blood Culture Identification Fungal Pathogen Panel

Two of Three ePlex Blood Culture Identification Panels Now Cleared for Marketing in the U.S. CARLSBAD, Calif., Dec. 26, 2018 […]

NASDAQ Companies - December 26, 2018

Immunomedics and Johnson Matthey Announce Strategic Manufacturing Partnership

Partnership Involves Large-Scale Production of CL2A-SN-38, the Drug-Linker Used in Immunomedics’ Lead Antibody-Drug Conjugate, Sacituzumab Govitecan MORRIS PLAINS, N.J. and […]

NASDAQ Companies - December 26, 2018

Neos Therapeutics Announces Settlement with Teva on Cotempla XR-ODT® Patent Litigation

DALLAS and FORT WORTH, Texas, Dec. 26, 2018 (GLOBE NEWSWIRE) — Neos Therapeutics, Inc. (Nasdaq:NEOS), a pharmaceutical company focused on […]

NASDAQ Companies - December 26, 2018

Myriad Announces Publication of Vectra® Study in Journal Rheumatology

Adjusted Vectra Test Is Up to Five Times More Effective for Predicting Radiographic Progression in Patients with Rheumatoid Arthritis than […]

NYSE Companies - December 26, 2018

GasLog Ltd. Announces Two Further Long-Term Charters With Cheniere And Places Newbuilding Orders At Samsung Heavy Industries

Monaco, Dec. 26, 2018 (GLOBE NEWSWIRE) — GasLog Ltd. (“GasLog”) (NYSE:GLOG) is pleased to announce that, as referenced in the […]

NASDAQ Companies - December 26, 2018

Athenex Pharmaceutical Division, an Athenex, Inc. Company, Launches Levothyroxine Sodium for Injection

BUFFALO, N.Y., Dec. 26, 2018 (GLOBE NEWSWIRE) — Athenex, Inc. (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development […]